
Stephen Gucker
Examiner (ID: 5682)
| Most Active Art Unit | 1649 |
| Art Unit(s) | 1646, 1812, 1818, 1649, 1645, 1647 |
| Total Applications | 799 |
| Issued Applications | 370 |
| Pending Applications | 114 |
| Abandoned Applications | 315 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 3988836
[patent_doc_number] => 05891638
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-04-06
[patent_title] => 'Serine threonine kinase receptor, alk-7'
[patent_app_type] => 1
[patent_app_number] => 8/957365
[patent_app_country] => US
[patent_app_date] => 1997-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14518
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/891/05891638.pdf
[firstpage_image] =>[orig_patent_app_number] => 957365
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/957365 | Serine threonine kinase receptor, alk-7 | Oct 23, 1997 | Issued |
Array
(
[id] => 3941757
[patent_doc_number] => 05976815
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-11-02
[patent_title] => 'Bioassay using ALK-7, a novel serine threonine kinase receptor'
[patent_app_type] => 1
[patent_app_number] => 8/957364
[patent_app_country] => US
[patent_app_date] => 1997-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16216
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/976/05976815.pdf
[firstpage_image] =>[orig_patent_app_number] => 957364
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/957364 | Bioassay using ALK-7, a novel serine threonine kinase receptor | Oct 23, 1997 | Issued |
Array
(
[id] => 1535652
[patent_doc_number] => 06489459
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-12-03
[patent_title] => 'Identification oh HOP-1 and uses thereof'
[patent_app_type] => B1
[patent_app_number] => 08/937834
[patent_app_country] => US
[patent_app_date] => 1997-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 13
[patent_no_of_words] => 11850
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/489/06489459.pdf
[firstpage_image] =>[orig_patent_app_number] => 08937834
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/937834 | Identification oh HOP-1 and uses thereof | Sep 24, 1997 | Issued |
Array
(
[id] => 1420146
[patent_doc_number] => 06506729
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-01-14
[patent_title] => 'Methods and compositions for the treatment and prevention of Parkinson\'s disease'
[patent_app_type] => B1
[patent_app_number] => 08/938622
[patent_app_country] => US
[patent_app_date] => 1997-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 16
[patent_no_of_words] => 28129
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/506/06506729.pdf
[firstpage_image] =>[orig_patent_app_number] => 08938622
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/938622 | Methods and compositions for the treatment and prevention of Parkinson's disease | Sep 24, 1997 | Issued |
Array
(
[id] => 4241533
[patent_doc_number] => 06221376
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-04-24
[patent_title] => 'Glial cell line-derived neurotrophic factor'
[patent_app_type] => 1
[patent_app_number] => 8/935268
[patent_app_country] => US
[patent_app_date] => 1997-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 37
[patent_no_of_words] => 27115
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/221/06221376.pdf
[firstpage_image] =>[orig_patent_app_number] => 935268
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/935268 | Glial cell line-derived neurotrophic factor | Sep 21, 1997 | Issued |
Array
(
[id] => 1371294
[patent_doc_number] => 06566496
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-05-20
[patent_title] => 'Neurogenin'
[patent_app_type] => B1
[patent_app_number] => 08/932411
[patent_app_country] => US
[patent_app_date] => 1997-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 24530
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/566/06566496.pdf
[firstpage_image] =>[orig_patent_app_number] => 08932411
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/932411 | Neurogenin | Sep 16, 1997 | Issued |
| 08/913579 | ASPARAGINYL TRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS | Sep 15, 1997 | Abandoned |
Array
(
[id] => 4297659
[patent_doc_number] => 06187310
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-02-13
[patent_title] => 'Recombinant Entamoeba histolytica lectin subunit peptides and reagents specific for members of the 170 kDa subunit multigene family'
[patent_app_type] => 1
[patent_app_number] => 8/937236
[patent_app_country] => US
[patent_app_date] => 1997-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 14
[patent_no_of_words] => 17427
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/187/06187310.pdf
[firstpage_image] =>[orig_patent_app_number] => 937236
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/937236 | Recombinant Entamoeba histolytica lectin subunit peptides and reagents specific for members of the 170 kDa subunit multigene family | Sep 15, 1997 | Issued |
Array
(
[id] => 1056314
[patent_doc_number] => 06855537
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-02-15
[patent_title] => 'Macrophage-infecting parasites expressing a granulocyte macrophage colony stimulated factor'
[patent_app_type] => utility
[patent_app_number] => 08/931721
[patent_app_country] => US
[patent_app_date] => 1997-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 10
[patent_no_of_words] => 4859
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/855/06855537.pdf
[firstpage_image] =>[orig_patent_app_number] => 08931721
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/931721 | Macrophage-infecting parasites expressing a granulocyte macrophage colony stimulated factor | Sep 15, 1997 | Issued |
Array
(
[id] => 4239918
[patent_doc_number] => 06080753
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-06-27
[patent_title] => 'Stimulating nerve growth with immunophilins'
[patent_app_type] => 1
[patent_app_number] => 8/931070
[patent_app_country] => US
[patent_app_date] => 1997-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 25
[patent_no_of_words] => 7551
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/080/06080753.pdf
[firstpage_image] =>[orig_patent_app_number] => 931070
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/931070 | Stimulating nerve growth with immunophilins | Sep 14, 1997 | Issued |
Array
(
[id] => 4179232
[patent_doc_number] => 06037320
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-03-14
[patent_title] => 'Neurotrophic factor (NT-4)'
[patent_app_type] => 1
[patent_app_number] => 8/928694
[patent_app_country] => US
[patent_app_date] => 1997-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 26941
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/037/06037320.pdf
[firstpage_image] =>[orig_patent_app_number] => 928694
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/928694 | Neurotrophic factor (NT-4) | Sep 11, 1997 | Issued |
| 08/889354 | NOVEL PROTEINS WITHIN THE TYPE E BOTULINUM NEUROTOXIN COMPLEX | Jul 7, 1997 | Abandoned |
Array
(
[id] => 4407053
[patent_doc_number] => 06265175
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-07-24
[patent_title] => 'Method for production of neuroblasts'
[patent_app_type] => 1
[patent_app_number] => 8/884427
[patent_app_country] => US
[patent_app_date] => 1997-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 17
[patent_no_of_words] => 14112
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 171
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/265/06265175.pdf
[firstpage_image] =>[orig_patent_app_number] => 884427
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/884427 | Method for production of neuroblasts | Jun 26, 1997 | Issued |
Array
(
[id] => 4090059
[patent_doc_number] => 06096322
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-08-01
[patent_title] => 'Pathogenicity and protective attributes of major clones of Escherichia coli recovered from chickens during processing'
[patent_app_type] => 1
[patent_app_number] => 8/880844
[patent_app_country] => US
[patent_app_date] => 1997-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5635
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/096/06096322.pdf
[firstpage_image] =>[orig_patent_app_number] => 880844
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/880844 | Pathogenicity and protective attributes of major clones of Escherichia coli recovered from chickens during processing | Jun 22, 1997 | Issued |
Array
(
[id] => 663054
[patent_doc_number] => 07101837
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-09-05
[patent_title] => 'Recombinant human alpha-fetoprotein as a cell proliferative agent'
[patent_app_type] => utility
[patent_app_number] => 08/879469
[patent_app_country] => US
[patent_app_date] => 1997-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5790
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/101/07101837.pdf
[firstpage_image] =>[orig_patent_app_number] => 08879469
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/879469 | Recombinant human alpha-fetoprotein as a cell proliferative agent | Jun 19, 1997 | Issued |
Array
(
[id] => 1449654
[patent_doc_number] => 06455276
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-09-24
[patent_title] => 'Human 4 receptor subunit of the GABA-A receptor'
[patent_app_type] => B1
[patent_app_number] => 08/809802
[patent_app_country] => US
[patent_app_date] => 1997-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 7650
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/455/06455276.pdf
[firstpage_image] =>[orig_patent_app_number] => 08809802
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/809802 | Human 4 receptor subunit of the GABA-A receptor | Jun 18, 1997 | Issued |
Array
(
[id] => 3764500
[patent_doc_number] => 05852171
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-12-22
[patent_title] => 'Cloning and regulation of an endothelial cell protein C/activated protein C receptor'
[patent_app_type] => 1
[patent_app_number] => 8/878283
[patent_app_country] => US
[patent_app_date] => 1997-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 15
[patent_no_of_words] => 10084
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/852/05852171.pdf
[firstpage_image] =>[orig_patent_app_number] => 878283
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/878283 | Cloning and regulation of an endothelial cell protein C/activated protein C receptor | Jun 17, 1997 | Issued |
Array
(
[id] => 4050611
[patent_doc_number] => 05932469
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-08-03
[patent_title] => 'Antimicrobial polypeptide, nucleic acid, and methods of use'
[patent_app_type] => 1
[patent_app_number] => 8/871924
[patent_app_country] => US
[patent_app_date] => 1997-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5778
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/932/05932469.pdf
[firstpage_image] =>[orig_patent_app_number] => 871924
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/871924 | Antimicrobial polypeptide, nucleic acid, and methods of use | Jun 9, 1997 | Issued |
Array
(
[id] => 4302072
[patent_doc_number] => 06326156
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-12-04
[patent_title] => 'Method of identifying compounds having antiepileptic anticonvulsant or anxiolytic activities'
[patent_app_type] => 1
[patent_app_number] => 8/868355
[patent_app_country] => US
[patent_app_date] => 1997-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6449
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/326/06326156.pdf
[firstpage_image] =>[orig_patent_app_number] => 868355
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/868355 | Method of identifying compounds having antiepileptic anticonvulsant or anxiolytic activities | Jun 2, 1997 | Issued |
Array
(
[id] => 3992245
[patent_doc_number] => 05919664
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-07-06
[patent_title] => 'Peptide release factor, prfC (RF-3), a GTP-Binding protein'
[patent_app_type] => 1
[patent_app_number] => 8/865311
[patent_app_country] => US
[patent_app_date] => 1997-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11637
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/919/05919664.pdf
[firstpage_image] =>[orig_patent_app_number] => 865311
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/865311 | Peptide release factor, prfC (RF-3), a GTP-Binding protein | May 28, 1997 | Issued |